Tianjin Medical University Cancer Institute and Hospital
sameAs
Comprehensive Analysis of Gene Mutation Profile in Chinese NSCLC Patients by Next-generation SequencingStudy of M2ES With Paclitaxel/Carboplatin (TC Regimen) in Advanced Non Small Cell Lung Cancer (NSCLC)Clinical Trial of Bile Etiology ,Proteomics and Metabonomics of Malignant Biliary ObstructionA Efficacy and Safety Study of Composite Gel Containing Black Raspberry Extract in Removing HPV From Patients With Cervical Intraepithelial Neoplasia(CIN) After Cervical ConizationEffect of Radiation and Its Timing on Breast Reconstruction in Chinese PatientsApplication of Intra-operative Prophylactic Antibiotics/Antiseptics in Chinese Breast Reconstruction PatientsStudy of Anlotinib Combined With Icotinib as the First-line Treatment in Patients With EGFR Mutation-positive NSCLCA Study to Compare Efficacy and Safety of DRT VS CRT Plus Surgery in Patients Who Achieved CCR for Esophageal CancerThe Criteria for Lymph Node Sorting for Pathological Examination in Gastric CancerNonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of Pancreatic CancerImpact of the Techniques for Intrathoracic Esophagogastric Anastomosis on Outcome in Ivor-Lewis OesophagectomyStudy of Apatinib Combined With TACE in Advance Hepatocellular CarcinomaXELOX/mFOLFOX Plus Vitamin D3 vs. XELOX/mFOLFOX as Firstline Chemotherapy in mCRCAdjuvant Chemotherapy for Biliary Tract Cancer After Curative ResectionThe MDA Test to Differentiate of Benign and Malignant Pulmonary NodulesCombination of Chemotherapy Plus RT and SHR-1210 to Treat Patients With ESCC
P859
Q43088767-7C9CFDD3-1665-4DC1-A44E-FE6CB659F045Q85732971-BD212FE8-64DA-4F66-9AAE-30038A436280Q86584281-98854F13-DE99-4844-BE7D-C67476A1E1C4Q88219244-7CC5F7AD-D696-4035-9ABF-819E29194301Q88927086-BB5823DF-8ABD-4AED-A3BE-7D079208CA0EQ88927087-036A9789-CEA0-4E1E-8B08-B511B695B3E8Q88927088-7F71BCA5-C018-49B1-8FEB-1FB0B5352593Q88927090-86242055-5720-4011-B90C-3F0E9E04C7F2Q88927091-4E5FB8E1-D524-441C-BE9E-AD3D0E927106Q88927092-874884EF-8998-41A3-BE84-E6D9E5E4FCC1Q88927093-9A86556E-DF66-4F91-A1F2-F56CB4F104EAQ89130800-AA3B7EE2-14E3-42D5-90F9-82D3D2344E74Q89141841-25121DCE-9C01-445E-B8A6-63703579F71EQ89653822-540A9C97-CB78-4B5C-A809-339E453938C1Q89974468-3F1BED27-5275-4D07-8F77-F12AF547CDC8
P108
Q61906917-2D84FA78-8B50-4446-AAF2-4102E4E09E51Q61936248-E7F657AA-E820-472C-846C-5BEB4189E6A3Q61938451-41E645A6-0F9B-4816-8170-80D817DDF5EBQ62034469-301ADE13-BB77-4240-9B1C-57BB5CEC07E3Q62034680-47FBD116-0256-4B5D-BC60-B5FF7C0C3AF9Q62034713-92FB9C60-36E3-4EA4-BC12-101F539B7F68Q62035457-90C28C47-DB90-41E8-89E7-97F37CCF62D5Q62042577-D6CC9CBA-0909-45D6-B4FB-E82A6DDF91ABQ62812466-9FD8DF74-9ABD-468A-A35E-350381B07729Q63011129-091998A1-0C62-4F98-AEBB-6EFF1A7617FDQ63340157-501E4E1A-9DB0-460B-84ED-20954BB6FB5CQ63402928-6A2F6080-B224-4DD4-BD6F-FB185CA40ABEQ63405382-3D7C6673-026C-4786-AA3A-6D0C8CC1777AQ63594831-0A04B9F2-6FF6-4335-BCD9-884C9CED3F6FQ63594884-806741C2-34FB-4F4F-826C-3AB82A762F11Q63598572-672C0BD4-69CF-4571-BF3B-3A6140BADE3C
P859
Tianjin Medical University Cancer Institute and Hospital
description
Krankenhaus
@de
griya sakit
@jv
hospital de República Popular China
@ast
hospital
@en
hôpital
@fr
rumah sakik
@min
rumah sakit di Republik Rakyat Tiongkok
@id
rumoh sakét
@ace
ziekenhuis in Tianjin, Volksrepubliek China
@nl
مستشفى في تيانجين، الصين
@ar
name
Tianjin Medical University Cancer Institute and Hospital
@en
天津市肿瘤医院
@zh
type
label
Tianjin Medical University Cancer Institute and Hospital
@en
天津市肿瘤医院
@zh
altLabel
天津医科大学肿瘤医院
@zh
天津医科大学附属肿瘤医院
@zh
天津肿瘤医院
@zh
prefLabel
Tianjin Medical University Cancer Institute and Hospital
@en
天津市肿瘤医院
@zh
P6366
P131
P213
0000 0004 1798 6427
P2427
grid.411918.4
P3500
P6366
2802573037